{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:22:40Z","timestamp":1707524560736},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,6,26]]},"DOI":"10.7759\/cureus.26351","type":"journal-article","created":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T01:20:55Z","timestamp":1656292855000},"source":"Crossref","is-referenced-by-count":0,"title":["Cardiac Arrest Induced by an Anaphylactic Reaction Associated With the First Dose of Cetuximab"],"prefix":"10.7759","author":[{"given":"Atsuya","family":"Hane","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asami","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Ishikura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Imai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinaga","family":"Okugawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2005.00785.x","article-title":"Epidemiology of life-threatening and lethal anaphylaxis: a review","volume":"60","author":"Moneret-Vautrin DA","year":"2005","unstructured":"Moneret-Vautrin DA, Morisset M, Flabbee J, Beaudouin E, Kanny G. Epidemiology of life-threatening and lethal anaphylaxis: a review. Allergy. 2005, 60:443-51. 10.1111\/j.1398-9995.2005.00785.x","journal-title":"Allergy"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.alit.2019.04.001","article-title":"Alpha-Gal-containing biologics and anaphylaxis","volume":"68","author":"Chinuki Y","year":"2019","unstructured":"Chinuki Y, Morita E. Alpha-Gal-containing biologics and anaphylaxis. Allergol Int. 2019, 68:296-300. 10.1016\/j.alit.2019.04.001","journal-title":"Allergol Int"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1908075","article-title":"Encorafenib, binimetinib, and cetuximab in BRAF V600E-mutated colorectal cancer","volume":"381","author":"Kopetz S","year":"2019","unstructured":"Kopetz S, Grothey A, Yaeger R, et al.. Encorafenib, binimetinib, and cetuximab in BRAF V600E-mutated colorectal cancer. N Engl J Med. 2019, 381:1632-43. 10.1056\/NEJMoa1908075","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s00105-022-04943-4","article-title":"[Alpha-gal syndrome: overview of clinical presentation and pathophysiology]","volume":"73","author":"Fischer J","year":"2022","unstructured":"Fischer J, Reepschl\u00e4ger T, Schricker T, Raap U. [Alpha-gal syndrome: overview of clinical presentation and pathophysiology]. Hautarzt. 2022, 73:195-200. 10.1007\/s00105-022-04943-4","journal-title":"Hautarzt"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-015-8503-x","article-title":"The epidemiology of anaphylaxis","volume":"54","author":"Yu JE","year":"2018","unstructured":"Yu JE, Lin RY. The epidemiology of anaphylaxis. Clin Rev Allergy Immunol. 2018, 54:366-74. 10.1007\/s12016-015-8503-x","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2222.2000.00864.x","article-title":"Lessons for management of anaphylaxis from a study of fatal reactions","volume":"30","author":"Pumphrey RS","year":"2000","unstructured":"Pumphrey RS. Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy. 2000, 30:1144-50. 10.1046\/j.1365-2222.2000.00864.x","journal-title":"Clin Exp Allergy"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2008.10.052","article-title":"Delayed anaphylaxis, angioedema, or urticaria after consumption of red meat in patients with IgE antibodies specific for galactose-alpha-1,3-galactose","volume":"123","author":"Commins SP","year":"2009","unstructured":"Commins SP, Satinover SM, Hosen J, et al.. Delayed anaphylaxis, angioedema, or urticaria after consumption of red meat in patients with IgE antibodies specific for galactose-alpha-1,3-galactose. J Allergy Clin Immunol. 2009, 123:426-33. 10.1016\/j.jaci.2008.10.052","journal-title":"J Allergy Clin Immunol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.20802","article-title":"Tick bite linked to red meat allergy","volume":"319","author":"Kuehn BM","year":"2018","unstructured":"Kuehn BM. Tick bite linked to red meat allergy. JAMA. 2018, 319:332. 10.1001\/jama.2017.20802","journal-title":"JAMA"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2020.12.019","article-title":"Diagnostic testing for galactose-alpha-1,3-galactose, United States, 2010 to 2018","volume":"126","author":"Binder AM","year":"2021","unstructured":"Binder AM, Commins SP, Altrich ML, et al.. Diagnostic testing for galactose-alpha-1,3-galactose, United States, 2010 to 2018. Ann Allergy Asthma Immunol. 2021, 126:411-6.e1. 10.1016\/j.anai.2020.12.019","journal-title":"Ann Allergy Asthma Immunol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa074943","article-title":"Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose","volume":"358","author":"Chung CH","year":"2008","unstructured":"Chung CH, Mirakhur B, Chan E, et al.. Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose. N Engl J Med. 2008, 358:1109-17. 10.1056\/NEJMoa074943","journal-title":"N Engl J Med"},{"key":"ref11","unstructured":"Prescribing information of Erbitux Injection 100 mg (in Japanese). (2022). Accessed. May 11, 2022: https:\/\/pins.japic.or.jp\/pdf\/newPINS\/00055812.pdf."},{"key":"ref12","article-title":"Alpha-gal anaphylaxis: the first case report in Italy","volume":"47","author":"Calamari AM","year":"2015","unstructured":"Calamari AM, Poppa M, Villalta D, Pravettoni V. Alpha-gal anaphylaxis: the first case report in Italy. Eur Ann Allergy Clin Immunol. 2015, 47:161-2.","journal-title":"Eur Ann Allergy Clin Immunol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/98015-cardiac-arrest-induced-by-an-anaphylactic-reaction-associated-with-the-first-dose-of-cetuximab","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:37:39Z","timestamp":1707507459000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/98015-cardiac-arrest-induced-by-an-anaphylactic-reaction-associated-with-the-first-dose-of-cetuximab"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,26]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.26351","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6,26]]}}}